|1.||Watanabe, Maiko: 2 articles (04/2014 - 01/2013)|
|2.||Sugita-Konishi, Yoshiko: 2 articles (04/2014 - 01/2013)|
|3.||Pestka, James J: 2 articles (04/2014 - 01/2013)|
|4.||Zhang, Haibin: 2 articles (04/2014 - 01/2013)|
|5.||Wu, Wenda: 2 articles (04/2014 - 01/2013)|
|6.||On, Stephen L W: 1 article (12/2014)|
|7.||Wang, Jianhua: 1 article (12/2014)|
|8.||Ediage, Emmanuel Njumbe: 1 article (12/2014)|
|9.||Yang, Xianli: 1 article (12/2014)|
|10.||Nie, Dongxia: 1 article (12/2014)|
|1.||Body Weight (Weight, Body)
12/01/2014 - "However, if the cumulative health risks were calculated based on the combined consideration of DON with either 3-ADON or 15-ADON or both, the DI values in 95th percentile were up to 1087 ng/kg body weight/day, exceeding the Provisional Maximum Tolerable Daily Intake (PMTDI) of 1000 ng/kg body weight/day and hence representing potential health risks to the population in Shanghai. "
12/01/1986 - "Growing female B6C3F1 mice were fed semi-purified diets containing 0, 0.5, 2.0 and 5.0 ppm 15-ADON over 56 days and assessed for effects on feed intake, body-weight gain, terminal organ weights and blood clotting function. "
12/01/1986 - "Decreased feed consumption and body-weight gain in the B6C3F1 mouse after dietary exposure to 15-acetyldeoxynivalenol."
11/01/1987 - "The emetic activity of 15-acetyldeoxynivalenol (15-ADON), a deoxynivalenol (DON) precursor, was evaluated in swine over a dose range of 25-200 micrograms/kg body weight and found to be very similar to that of DON. "
11/01/1987 - "For pigs receiving 15-ADON and DON ip, increased dosage was associated with decreased average time to vomition, increased duration of emesis and increased average number of vomitions."
11/01/1987 - "The minimum effective ip doses for 15-ADON and DON were also 75 and 50 micrograms/kg, respectively, with 9/15 pigs in each group exhibiting emesis, over the total dose range. "
11/01/1987 - "The minimum effective oral doses for 15-ADON and DON were 75 and 50 micrograms/kg, respectively, with 3/15 of the 15-ADON- and 4/15 of the DON-treated pigs exhibiting emesis, over the total dose range. "
01/01/2013 - "To address this, we compared potencies of DON, 15-acetyldeoxynivalenol (15-ADON), 3-acetyldeoxynivalenol (3-ADON), fusarenon X (FX), and nivalenol (NIV) in the mink emesis model following intraperitoneal (ip) and oral administration. "